ZYREXAL Trademark

Trademark Overview

On Tuesday, October 23, 2018, a trademark application was filed for ZYREXAL with the United States Patent and Trademark Office. The USPTO has given the ZYREXAL trademark a serial number of 88166503. The federal status of this trademark filing is REGISTERED as of Tuesday, May 3, 2022. This trademark is owned by Vivera Pharmaceuticals, Inc.. The ZYREXAL trademark is filed in the Pharmaceutical Products category with the following description:

Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders

General Information

Serial Number88166503
Word MarkZYREXAL
Filing DateTuesday, October 23, 2018
Status700 - REGISTERED
Status DateTuesday, May 3, 2022
Registration Number6719189
Registration DateTuesday, May 3, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 26, 2019

Trademark Statements

Goods and ServicesDrug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of prescription dosage capsules that facilitate the delivery of pharmaceutical preparations; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; all of the foregoing excluding pharmaceutical preparations and substances for the treatment of the central nervous system, sleep disorders, and neurological diseases or disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 5, 2018
Primary Code005
First Use Anywhere DateTuesday, October 23, 2018
First Use In Commerce DateThursday, December 5, 2019

Trademark Owner History

Party NameVivera Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameVivera Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660
Party NameVivera Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNewport Beach, CA 92660

Trademark Events

Event DateEvent Description
Thursday, March 7, 2024WITHDRAWAL OF ATTORNEY GRANTED
Thursday, March 7, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, May 3, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, March 31, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, March 30, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, March 25, 2022STATEMENT OF USE PROCESSING COMPLETE
Monday, February 28, 2022USE AMENDMENT FILED
Thursday, March 24, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 28, 2022TEAS STATEMENT OF USE RECEIVED
Friday, August 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 18, 2021SOU EXTENSION 4 GRANTED
Wednesday, August 18, 2021SOU EXTENSION 4 FILED
Wednesday, August 18, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, February 27, 2021SOU EXTENSION 3 GRANTED
Saturday, February 27, 2021SOU EXTENSION 3 FILED
Saturday, February 27, 2021SOU TEAS EXTENSION RECEIVED
Thursday, February 25, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 25, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 25, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 8, 2020WITHDRAWAL OF ATTORNEY GRANTED
Thursday, October 8, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Saturday, August 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 27, 2020SOU EXTENSION 2 GRANTED
Thursday, August 27, 2020SOU EXTENSION 2 FILED
Thursday, August 27, 2020SOU TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020SOU EXTENSION 1 GRANTED
Thursday, February 27, 2020SOU EXTENSION 1 FILED
Thursday, February 27, 2020SOU TEAS EXTENSION RECEIVED
Wednesday, November 13, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 13, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 27, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, July 17, 2019CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Thursday, July 11, 2019ASSIGNED TO PETITION STAFF
Sunday, July 7, 2019EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Thursday, June 20, 2019TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, April 22, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 22, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 28, 2019EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, February 26, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 26, 2019PUBLISHED FOR OPPOSITION
Wednesday, February 6, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 17, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 15, 2019ASSIGNED TO EXAMINER
Monday, November 5, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 26, 2018NEW APPLICATION ENTERED

Related Keywords

zyrexal delivery agents drug wide form variety preparations pharmaceuticals pharmaceutical release